Agreed. Primed to run now, pro-shake I think. No reason to be sold down on +9% receipts. Buy side also looking better now.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025